| 14-Feb-2017 | S | Advanced Enzyme Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 14, 2017, (commenced at 11.00 A.M. and concluded at 1.00 P.M.) inter alia, has approved the following:
Subject to approval of the shareholders of the Company and other statutory / regulatory approvals: (a) Sub-Division of face value of share capital of the Company from existing Rs. 10 (Rupees Ten) per share to Rs. 2 (Rupees Two) per share and consequent alteration in capital clause of Memorandum of Association of the Company.
Pursuant to Regulations 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Company has fixed the Record Date for the purpose of sub-division of equity shares of the Company.
(As Per BSE Announcement Dated On 06/05/2017)
Trading Members of the Exchange are hereby informed that Advanced Enzyme Technologies Limited has fixed Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Advanced Enzyme Technologies Limited
(540025)
RECORD DATE
26/05/2017
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into FIVE equity shares of Rs. 2/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.2/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
25/05/2017 DR- 038/2017-2018
Note:-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs. 2/- paid up w.e.f. 25/05/2017.
ii. ISIN No. INE837H01012 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 25/05/2017.
iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As Per BSE notice Dated on 10.05.2017) | 26-May-2017 | |
| 13-May-2023 | D | Approved the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2023 along with fourth quarter results. Recommended a Final Dividend @ 50% i.e. Re. 1/- per Equity Share on the face value of Rs. 2/- each for the financial year 23, subject to the approval of the Shareholders at the ensuing 34th Annual General Meeting of the Company ('AGM').The Final Dividend, if approved / declared by the Shareholders at 34th AGM, will be paid on and from the second day from the date of AGM. Declared an Interim Dividend @ 200% i.e. Re. 4/- per Equity Share on the face value of Rs. 2/- each for the financial year 2023-24.
Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 , it is hereby informed that Record Date has been fixed as Saturday, August 05, 2023, for the purpose of ascertaining the entitlement of the Members to the final dividend for FY 2023, if approved(declared) at the 34th AGM
(As Per BSE Announcement Dated on 08/07/2023)
| 04-Aug-2023 | |
| 13-May-2023 | D | Approved the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2023 along with fourth quarter results. Recommended a Final Dividend @ 50% i.e. Re. 1/- per Equity Share on the face value of Rs. 2/- each for the financial year 23, subject to the approval of the Shareholders at the ensuing 34th Annual General Meeting of the Company ('AGM').The Final Dividend, if approved / declared by the Shareholders at 34th AGM, will be paid on and from the second day from the date of AGM. Declared an Interim Dividend @ 200% i.e. Re. 4/- per Equity Share on the face value of Rs. 2/- each for the financial year 2023-24. | 19-May-2023 | |
| 20-May-2022 | D | The Company has informed the exchange that the Board of Directors of the Company at its meeting held on May 22, 2022, inter alia, has recommended a Dividend @ 50% i.e. Rs. 1/- per Equity Share on the face value of Rs. 2/- each for the financial year ended March 31, 2022, subject to the approval of the Shareholders at the ensuing 33rd Annual General Meeting of the Company ('AGM'). The Dividend, if approved / declared by the Shareholders at 33rd AGM, will be paid on and from the second day from the date of AGM. Record date for the entitlement of Dividend, and date & timings for ensuing Annual General Meeting of the Company shall be intimated in due course of time. | 11-Aug-2022 | |
| 29-May-2021 | D | Advanced Enzyme Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2021, inter alia, has recommended a Dividend @ 45% i.e. Rs. 0.90/- per Equity Share on the face value of Rs. 2/- each for the financial year ended March 31, 2021, subject to the approval of the Shareholders at the ensuing 32nd Annual General Meeting of the Company ('AGM').
The Dividend, if approved / declared by the Shareholders at 32nd AGM, will be paid on and from the second day from the date of AGM. | 31-Aug-2021 | |
| 30-May-2020 | D | With reference to the notice of Board Meeting dated May 23, 2020, we hereby inform that the Board of Directors in its Meeting held on May 30, 2020 (commenced at 12:30 p.m. and concluded at 1:35 p.m.) has inter alia, transacted the following business:
Recommended a Dividend @ 30% i.e. Rs. 0.60/- per equity share on the face value of Rs. 2/- each for the financial year ended March 31, 2020, subject to the approval of the hareholders at the ensuing 31st Annual General Meeting of the Company ('AGM'). | 09-Jul-2020 | |
| 24-May-2019 | D | The Board has recommended a Dividend @ 30% i.e. Rs. 0.60 per equity share on the face value of Rs. 2 each for the financial year ended March 31, 2019, subject to the approval of the Shareholders at the ensuing 30th Annual General Meeting of the Company. | 01-Aug-2019 | |
| 19-May-2018 | D | The Board of Directors in its Meeting held on May 19, 2018 has inter alia, transact the following business:
1. Recommended a Dividend @ 25% i.e. Rs. 0.50 per equity share on the face value of Rs. 2 each for the financial year ended March 31, 2018, subject to the approval of the Shareholders at the ensuing 29th Annual General Meeting of the Company.
The Dividend, if approved / declared by the Shareholders at 29th Annual General Meeting, will be paid on and from the second (2nd) day from the date of 29th Annual General Meeting (AGM).
Book Closure period for the entitlement of the Dividend shall be intimated in due course of time.
2. 29th Annual General Meeting (AGM) of the Members of Advanced Enzyme Technologies Limited will be held on Friday, September 14, 2018, at 11.30 a.m. at Shehnai Banquet Hall, Shahid Mangal Pandey Road, Louiswadi, Opposite Louis Wadi Police Chowki, Thane (West) - 400601. | 06-Sep-2018 | |
| 27-May-2017 | D | Advanced Enzyme Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2017, inter alia, has recommended a Dividend @ 20% i.e. Rs. 0.40 per equity share on the face value of Rs. 2 each for the financial year ended March 31, 2017, subject to the approval of the Shareholders at the ensuing 28th Annual General Meeting of the Company.
The Dividend, if approved / declared by the Shareholders at 28th Annual General Meeting, will be paid on and from the second (2nd) day from the date of 28th Annual General Meeting (AGM).
Revised Dividend Payment Date
(As Per BSE Announcement Dated On 09/08/2017) | 04-Sep-2017 | |
| 13-May-2023 | BC | Approved the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2023 along with fourth quarter results. Recommended a Final Dividend @ 50 | 31-Mar-2024 | |
| 30-Mar-2024 | BC | Mr. Kedar Desai Independent Director will cease to be the Director of the Company with effect from March 31 2024 (end of business hours) due to completion of his second term of five years as an Inde | 31-Mar-2024 | |
| 22-Feb-2024 | BC | Advanced Vital Enzymes Pvt Ltd | 21-Feb-2024 | |
| 20-Feb-2024 | BC | Advanced Vital Enzymes Pvt Ltd | 19-Feb-2024 | |
| 20-Feb-2024 | BC | Advanced Vital Enzymes Pvt Ltd | 16-Feb-2024 | |